CVS Health Stock Price, Forecast & Analysis (NYSE:CVS)

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, October 3rd. Stockholders of record on Thursday, October 24th will be given a dividend of $0.50 per share on Monday, November 4th. This represents a $2.00 annualized dividend and a dividend yield of 2.69%. The ex-dividend date of this dividend is Wednesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) posted its quarterly earnings data on Wednesday, November, 6th. The pharmacy operator reported $1.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.77 by $0.07. The pharmacy operator earned $64.81 billion during the quarter, compared to the consensus estimate of $62.99 billion. CVS Health had a return on equity of 15.45% and a net margin of 1.83%. The firm's revenue was up 36.5% compared to the same quarter last year. During the same period last year, the firm earned $1.73 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of $6.97-7.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.98.

26 brokers have issued 12 month price targets for CVS Health's shares. Their forecasts range from $61.00 to $91.00. On average, they expect CVS Health's share price to reach $77.59 in the next twelve months. This suggests a possible upside of 4.4% from the stock's current price. View Analyst Price Targets for CVS Health.

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 7 hold ratings, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Press coverage about CVS stock has been trending neutral on Saturday, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CVS Health earned a news impact score of 0.2 on InfoTrie's scale. They also gave news stories about the pharmacy operator a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), NVIDIA (NVDA), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Verizon Communications (VZ), Home Depot (HD), Intel (INTC) and Bank of America (BAC).

CVS Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Parnassus Investments CA (0.64%), Veritas Asset Management LLP (0.52%), Sumitomo Mitsui Trust Holdings Inc. (0.38%), California Public Employees Retirement System (0.24%), Coho Partners Ltd. (0.20%) and Rhumbline Advisers (0.18%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, Focused Investors LLC, Sumitomo Mitsui Trust Holdings Inc., Diamond Hill Capital Management Inc., Russell Investments Group Ltd., State of New Jersey Common Pension Fund D, Alta Capital Management LLC and Rothschild Investment Corp IL. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was acquired by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Artemis Investment Management LLP, Haverford Trust Co., California Public Employees Retirement System, Polaris Greystone Financial Group LLC, Atalanta Sosnoff Capital LLC, Assenagon Asset Management S.A. and Poplar Forest Capital LLC. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $74.29.

CVS Health has a market capitalization of $96.65 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]